Načítá se...
The role of metabolic therapy in treating glioblastoma multiforme
Glioblastoma multiforme (GBM) is an aggressive and nearly uniformly fatal malignancy of the central nervous system. Despite extensive research and clinical trials over the past 50 years, very little progress has been made to significantly alter its lethal prognosis. The current standard of care (SOC...
Uloženo v:
| Vydáno v: | Surg Neurol Int |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications & Media Pvt Ltd
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4405891/ https://ncbi.nlm.nih.gov/pubmed/25949849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2152-7806.155259 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|